Evaluation of the human type 3 adenoviral dodecahedron as a vector to target acute myeloid leukemia.

Autor: Caulier B; University Grenoble Alpes, CNRS, CHU Grenoble Alpes, Grenoble INP, TIMC-IMAG, 38000 Grenoble, France.; Institute of Biology and Pathology, Laboratory of Cellular Hematology, University Grenoble Alpes Hospital, Grenoble, France.; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, University Grenoble Alpes, Grenoble, France., Stofleth G; Institute of Biology and Pathology, Laboratory of Cellular Hematology, University Grenoble Alpes Hospital, Grenoble, France.; Department of Pediatric Onco-Immuno-Hematology, University Grenoble Alpes Hospital, Grenoble, France., Hannani D; University Grenoble Alpes, CNRS, CHU Grenoble Alpes, Grenoble INP, TIMC-IMAG, 38000 Grenoble, France., Guidetti M; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, University Grenoble Alpes, Grenoble, France., Josserand V; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, University Grenoble Alpes, Grenoble, France., Laurin D; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, University Grenoble Alpes, Grenoble, France.; Etablissement Français du Sang Auvergne Rhône-Alpes, Grenoble, France., Chroboczek J; University Grenoble Alpes, CNRS, CHU Grenoble Alpes, Grenoble INP, TIMC-IMAG, 38000 Grenoble, France., Mossuz P; Institute of Biology and Pathology, Laboratory of Cellular Hematology, University Grenoble Alpes Hospital, Grenoble, France.; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, University Grenoble Alpes, Grenoble, France., Plantaz D; Department of Pediatric Onco-Immuno-Hematology, University Grenoble Alpes Hospital, Grenoble, France.

Publikováno v: Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2020 Nov 17; Vol. 20, pp. 181-190. Date of Electronic Publication: 2020 Nov 17 (Print Publication: 2021).